Q2 2025 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2025-08-14 · accession 0001420506-25-002183
$2.92B
Reported value
55
Positions
2025-06-30
Period end
The Brief · BRAIDWELL LP · Q2 2025
AI · grounded in 13F
BRAIDWELL LP established a new position in Guardant Health Inc [[stock:GH 1.25 02/15/31]] valued at $256.4M. The fund also initiated new stakes in Caris Life Sciences Inc CAI for $195.5M and Neurocrine Biosciences Inc NBIX for $145.9M. These moves contributed to a total AUM of $2.9B across 55 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAD1 | GH 1.25 02/15/31 | GUARDANT HEALTH INC | $256.4M | 8.77% | 219,454,000 | Common | SOLE |
| 142152107 | CAI | CARIS LIFE SCIENCES INC | $195.5M | 6.69% | 7,316,142 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $145.9M | 4.99% | 1,160,425 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $137.8M | 4.71% | 140,834,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $112.8M | 3.86% | 3,605,029 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $107.2M | 3.67% | 194,491 | Common | SOLE |
| 759916AD1 | RGEN 1 12/15/28 | REPLIGEN CORP | $100.5M | 3.44% | 101,000,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $100.0M | 3.42% | 727,811 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $94.0M | 3.22% | 496,730 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $90.2M | 3.09% | 2,542,104 | Common | SOLE |
| 450056AB2 | IRTC 1.5 09/01/29 | IRHYTHM TECHNOLOGIES INC | $90.0M | 3.08% | 70,000,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $89.7M | 3.07% | 1,175,876 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $87.1M | 2.98% | 101,381,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $85.4M | 2.92% | 3,283,317 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $78.4M | 2.68% | 92,740,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $68.3M | 2.34% | 5,210,831 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $67.8M | 2.32% | 522,410 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $64.2M | 2.20% | 1,478,512 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $62.3M | 2.13% | 603,414 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $61.1M | 2.09% | 309,339 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $54.8M | 1.88% | 135,233 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $48.7M | 1.67% | 89,600 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $46.2M | 1.58% | 300,029 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $45.0M | 1.54% | 3,863,107 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $43.6M | 1.49% | 837,800 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $40.4M | 1.38% | 3,635,172 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $38.6M | 1.32% | 2,578,404 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $38.1M | 1.30% | 1,437,555 | Common | SOLE |
| 48576UAD8 | KPTI 6 05/13/29 * | KARYOPHARM THERAPEUTICS INC | $35.5M | 1.22% | 48,482,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $34.2M | 1.17% | 255,048 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $33.3M | 1.14% | 129,628 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $31.2M | 1.07% | 3,273,349 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $30.5M | 1.04% | 1,102,580 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $26.6M | 0.91% | 872,246 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $23.8M | 0.81% | 1,107,770 | Common | SOLE |
| 45258DAB1 | IMCR 2.5 02/01/30 | IMMUNOCORE HLDGS PLC | $23.3M | 0.80% | 26,828,000 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $20.1M | 0.69% | 8,353,287 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $19.4M | 0.66% | 1,121,034 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $18.8M | 0.64% | 1,081,855 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $18.4M | 0.63% | 60,781 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $18.2M | 0.62% | 18,500,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $18.0M | 0.61% | 144,556 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $17.1M | 0.58% | 1,524,842 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $16.8M | 0.57% | 822,735 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $15.4M | 0.53% | 49,400 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $14.6M | 0.50% | 247,200 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $14.2M | 0.48% | 2,181,598 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $13.0M | 0.45% | 1,655,690 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $11.8M | 0.40% | 884,306 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $5.8M | 0.20% | 5,818,000 | Common | SOLE |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $4.2M | 0.14% | 261,504 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.9M | 0.13% | 422,887 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $2.6M | 0.09% | 2,472,806 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $1.9M | 0.07% | 752,541 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.3M | 0.04% | 140,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.